Skip to content

Effect of Phenol Addition to Laser Treatment on Epithelialization and Healing Process in Pilonidal Sinus

Effect of Phenol Addition to Laser Treatment on Epithelialization and Healing Process in Pilonidal Sinus: A Prospective Randomized Controlled Clinical Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07023952
Acronym
PLEPS
Enrollment
130
Registered
2025-06-17
Start date
2025-05-01
Completion date
2025-11-01
Last updated
2025-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laser Therapy, Pilonidal Sinus Disease

Keywords

Minimally Invasive Treatment, Day Surgery

Brief summary

This study compares two treatment approaches for pilonidal sinus disease: laser treatment alone versus laser treatment combined with phenol application. Pilonidal sinus is a common condition that affects young adults and can cause significant discomfort and time off work. Participants will be randomly assigned to receive either laser treatment only (Group A) or laser treatment plus phenol application (Group B). Both treatments are minimally invasive and performed under local anesthesia as day surgery procedures. The main goal is to determine if adding phenol to laser treatment speeds up the healing process (epithelialization) and improves patient outcomes. We will measure healing time, pain levels, return to daily activities, and quality of life over a 3-month follow-up period. This research may help develop more effective treatment protocols that reduce healing time and improve patient comfort for people with pilonidal sinus disease.

Detailed description

This prospective randomized controlled clinical trial investigates whether adding crystallized phenol to laser treatment improves epithelialization and healing outcomes in patients with pilonidal sinus disease. The study will be conducted at Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital. Study Design: 130 patients meeting inclusion criteria will be randomly assigned using computer randomization to two treatment groups (65 patients each): Group A: Laser treatment only using SiLaC (Sinus Laser Closure) technique Group B: Combined phenol application followed by laser treatment Treatment Procedures: Group A receives local anesthesia, pilonidal sinus area cleaning, assessment of sinus openings, and laser probe application into sinus channels. Group B receives local anesthesia, sinus area cleaning and curettage, crystallized phenol application into sinus channels, neutralization with saline after a specified time, followed by laser treatment. Both groups receive standard post-operative wound care instructions and same-day discharge. Follow-up Schedule: Preoperative assessment Postoperative visits at 2 weeks, 4 weeks, and 3 months Clinical examination for epithelialization status Pain assessment using Visual Analog Scale (VAS 0-10) Quality of life evaluation using SF-36 questionnaire Statistical Analysis: R software will be used for statistical analysis. Student's t-test or Mann-Whitney U test for continuous variables, chi-square test for categorical variables, and paired t-test for pre/post-treatment comparisons. Statistical significance set at p\<0.05. Primary Outcome: Time to complete epithelialization Secondary Outcomes: Postoperative pain scores, return to daily activities time, patient satisfaction, quality of life scores, and complication rates.

Interventions

PROCEDURELaser Treatment

Minimally invasive laser ablation procedure performed under local anesthesia for pilonidal sinus treatment. Laser energy is delivered through a fiber optic probe inserted into the sinus tract to achieve thermal ablation of the sinus cavity.

rystallized phenol is applied directly into the pilonidal sinus channels after cleaning and curettage. The phenol remains in contact for a specified duration before being neutralized with normal saline irrigation.

Sponsors

Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

Open-label study due to the nature of surgical interventions which cannot be blinded to participants or care providers

Intervention model description

Two parallel groups: Group A receives laser treatment only, Group B receives combined phenol and laser treatment

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years and older * Primary pilonidal sinus disease * Three or fewer pit counts * Willing to participate in the study and signed informed consent form * Able to attend follow-up visits

Exclusion criteria

* Age under 18 years * More than three pit counts * Acute abscess presentation * Bilateral lateral extension * Recurrent pilonidal sinus disease * Immunocompromised patients * Patients unable to attend follow-up visits * Pregnancy (if applicable) * Severe comorbidities that contraindicate surgery under local anesthesia

Design outcomes

Primary

MeasureTime frameDescription
Time to Complete EpithelializationFrom date of surgery until complete epithelialization is achieved, assessed up to 3 monthsTime required for complete epithelialization of the pilonidal sinus wound, assessed by clinical examination during follow-up visits. Complete epithelialization is defined as full closure of the wound with healthy epithelial tissue covering the entire treated area.

Secondary

MeasureTime frameDescription
Postoperative Pain ScoresMeasured at 2 weeks, 4 weeks, and 3 months post-surgeryPain intensity measured using Visual Analog Scale (VAS) ranging from 0 (no pain) to 10 (worst pain imaginable)
Return to Daily Activities TimeFrom date of surgery until return to normal activities, assessed up to 3 monthsTime required for patients to return to normal daily activities and work, measured in days from surgery
Complication RateFrom surgery through 3 months follow-upIncidence of post-operative complications including infection, wound dehiscence, bleeding, or other adverse events
Patient Satisfaction- VAS score Patient Satisfaction Patient SatisfactionAt 3 months post-surgeryPatient satisfaction measured using Visual Analog Scale (VAS) ranging from 0 (completely dissatisfied) to 10 (completely satisfied), where higher scores indicate better satisfaction

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026